Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach

被引:46
作者
Baas, IO
van Rees, BP
Musler, A
Craanen, ME
Tytgat, GNJ
van den Berg, FM
Offerhaus, GJA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1100 DE Amsterdam, Netherlands
关键词
stomach; gastric stump; carcinoma; p53; H pylori; Epstein-Barr virus;
D O I
10.1136/jcp.51.9.662
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim-To evaluate similarities and differences between gastric stump cancer and conventional carcinoma in the nonoperated stomach. Methods-26 stump carcinomas were compared with 24 conventional stomach cancers. Stage, histological type, and demographics were comparable in the two groups. Expression of p53 and p21-Waf1/Cip1 was evaluated by immunohistochemical staining. Helicobacter pylori infection was evaluated by examining haematoxylin-eosin stained slides and immunohistochemistry. Epstein-Barr virus infection was evaluated by RNA in situ hybridisation. Results-Expression of p53 and p21-Waf1/Cip1 was similar in both groups and positive in more than half of the patients. Helicobacter pylori infection was observed in six stump carcinomas and 17 conventional carcinomas in the intact stomach (p < 0.01). RNA in situ hybridisation (EBER1-ISH) for Epstein-Barr virus was positive in nine stump carcinomas and two carcinomas in the non-operated stomach (p < 0.05). Conclusions-There appear to be aetiological differences between stump carcinoma and cancer in the intact stomach. Further study of these differences may improve our understanding of gastric carcinogenesis in general.
引用
收藏
页码:662 / 666
页数:5
相关论文
共 36 条
[1]  
Baas IO, 1996, J PATHOL, V178, P264, DOI 10.1002/(SICI)1096-9896(199603)178:3<264::AID-PATH485>3.0.CO
[2]  
2-#
[3]   EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS [J].
BAAS, IO ;
MULDER, JWR ;
OFFERHAUS, GJA ;
VOGELSTEIN, B ;
HAMILTON, SR .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :5-12
[4]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[5]  
CAYGILL CPJ, 1986, LANCET, V1, P929
[6]  
CORREA P, 1982, CANCER-AM CANCER SOC, V50, P2554
[7]  
CORREA P, 1988, CANCER RES, V48, P3554
[8]   CHRONOLOGY OF P53 PROTEIN ACCUMULATION IN GASTRIC CARCINOGENESIS [J].
CRAANEN, ME ;
BLOK, P ;
DEKKER, W ;
OFFERHAUS, GJA ;
TYTGAT, GNJ .
GUT, 1995, 36 (06) :848-852
[9]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[10]  
ELDEIRY WS, 1995, CANCER RES, V55, P2910